Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 1:12 PM UTC
| NCT Number | NCT06297226 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 230 participants |
| Active Locations | 41 sites in the US |
| Sponsor | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
| Last Updated on CT.gov | May 28, 2026 (May 28, 2026) |
As of July 19, 2026: Clinical trial NCT06297226 is currently recruiting participants. This phase2 study for multiple myeloma is actively seeking new participants at 41 locations across the United States. The study is sponsored by Juno Therapeutics, Inc., a Bristol-Myers Squibb Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06297226 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 41 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06297226 was last updated May 28, 2026 (May 28, 2026). HelloStudys verifies this status automatically.